• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类 γδ T 淋巴细胞通过与调理靶细胞的相互作用获得专业抗原呈递的许可。

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.

机构信息

Molecular Haematology and Cancer Biology, University College London Institute of Child Health, London WCN1 1EH, UK.

出版信息

J Immunol. 2012 Feb 15;188(4):1708-16. doi: 10.4049/jimmunol.1102654. Epub 2012 Jan 16.

DOI:10.4049/jimmunol.1102654
PMID:22250090
Abstract

Activated human blood γδ T cells have also been previously demonstrated to behave as professional APCs, although the processes that control APC function have not been characterized. n this study, we show that the acquisition of potent APC function by human blood γδ T cells is achieved after physical interaction with an Ab-coated target cell, a process that we refer to as licensing. In cancer models, licensing of γδ T cells by tumor-reactive mAbs promotes the uptake of tumor Ags and professional presentation to tumor-reactive αβ T cells. We propose that licensing by Ab is a mechanism whereby the adaptive properties of γδ T cells are induced by their innate functions in a spatially and temporally controlled manner.

摘要

已有人证明,活化的人血 γδ T 细胞也可以作为专职抗原提呈细胞(APC)发挥作用,尽管控制 APC 功能的过程尚未被阐明。在本研究中,我们发现,人血 γδ T 细胞获得强大的 APC 功能是在与 Ab 包被的靶细胞发生物理相互作用之后实现的,我们将此过程称为“许可”。在癌症模型中,肿瘤反应性 mAb 对 γδ T 细胞的“许可”作用促进了肿瘤抗原的摄取和向肿瘤反应性 αβ T 细胞的专业呈递。我们提出,Ab 的“许可”作用是 γδ T 细胞的固有功能通过空间和时间控制的方式诱导其适应性特性的一种机制。

相似文献

1
Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.人类 γδ T 淋巴细胞通过与调理靶细胞的相互作用获得专业抗原呈递的许可。
J Immunol. 2012 Feb 15;188(4):1708-16. doi: 10.4049/jimmunol.1102654. Epub 2012 Jan 16.
2
Professional antigen-presentation function by human gammadelta T Cells.人类γδ T细胞的专业抗原呈递功能。
Science. 2005 Jul 8;309(5732):264-8. doi: 10.1126/science.1110267. Epub 2005 Jun 2.
3
Gammadelta T cells: an alternative type of professional APC.γδ T细胞:一种另类的专职抗原呈递细胞。
Trends Immunol. 2006 Mar;27(3):112-8. doi: 10.1016/j.it.2006.01.002. Epub 2006 Jan 25.
4
Immunology. Now presenting: gammadelta T cells.免疫学。现在介绍:γδ T细胞。
Science. 2005 Jul 8;309(5732):252-3. doi: 10.1126/science.1115264.
5
Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.抗半乳糖(Anti-Gal)介导的人B淋巴瘤细胞靶向抗原呈递细胞:一种使用自体肿瘤细胞进行免疫治疗的潜在方法。
Haematologica. 2005 May;90(5):625-34.
6
gammadelta T cells: novel initiators of adaptive immunity.γδ T细胞:适应性免疫的新型启动者。
Immunol Rev. 2007 Feb;215:89-102. doi: 10.1111/j.1600-065X.2006.00472.x.
7
Comparative gene expression by WC1+ gammadelta and CD4+ alphabeta T lymphocytes, which respond to Anaplasma marginale, demonstrates higher expression of chemokines and other myeloid cell-associated genes by WC1+ gammadelta T cells.对边缘无形体产生反应的WC1 + γδ和CD4 + αβ T淋巴细胞的比较基因表达显示,WC1 + γδ T细胞中趋化因子和其他髓样细胞相关基因的表达更高。
J Leukoc Biol. 2006 Oct;80(4):939-52. doi: 10.1189/jlb.0506353.
8
Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.人类γδ T细胞作为嵌合受体重定向抗肿瘤免疫的介质。
Br J Haematol. 2004 Aug;126(4):583-92. doi: 10.1111/j.1365-2141.2004.05077.x.
9
Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.由白细胞介素-12和白细胞介素-2联合诱导人外周血淋巴细胞产生的具有自然杀伤细胞标志物CD56的细胞毒性γδ或αβ T细胞。
J Immunol. 1996 Nov 1;157(9):3886-92.
10
Antigen-presenting cells for naive transgenic gamma delta T cells. Potent activation by activated alpha beta T cells.用于初始转基因γδ T细胞的抗原呈递细胞。被活化的αβ T细胞强力激活。
J Immunol. 1995 Oct 15;155(8):3866-76.

引用本文的文献

1
Engineering innate immune cells for cancer immunotherapy.通过工程改造天然免疫细胞进行癌症免疫治疗。
Nat Biotechnol. 2025 Apr;43(4):516-533. doi: 10.1038/s41587-025-02629-5. Epub 2025 Apr 14.
2
Gamma delta T cells and their immunotherapeutic potential in cancer.γδ T细胞及其在癌症中的免疫治疗潜力。
Biomark Res. 2025 Mar 28;13(1):51. doi: 10.1186/s40364-025-00762-6.
3
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth.急性HIV-1感染中表达CD16和CD57的γδT细胞与中和广度的发展相关。
PLoS Pathog. 2025 Jan 31;21(1):e1012916. doi: 10.1371/journal.ppat.1012916. eCollection 2025 Jan.
4
Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments.癌症治疗中的γδ T细胞:从肿瘤识别到新型治疗方法
Front Med (Lausanne). 2024 Dec 19;11:1480191. doi: 10.3389/fmed.2024.1480191. eCollection 2024.
5
A GD (Gamma-Delta) type of cancel culture.一种伽马-德尔塔(GD)类型的取消文化。
Immunooncol Technol. 2024 Nov 5;24:100740. doi: 10.1016/j.iotech.2024.100740. eCollection 2024 Dec.
6
A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study.一项旨在识别良性前列腺增生发病机制和药物靶点的遗传学研究:多组学孟德尔随机化研究。
Sci Rep. 2024 Oct 4;14(1):23120. doi: 10.1038/s41598-024-73466-w.
7
Synthetic BSA-conjugated disaccharide related to the serotype 3 capsular polysaccharide increases IL-17A Levels, γδ T cells, and B1 cells in mice.合成的与血清型 3 荚膜多糖相关的 BSA 缀合二糖增加了小鼠中的 IL-17A 水平、γδ T 细胞和 B1 细胞。
Front Immunol. 2024 May 22;15:1388721. doi: 10.3389/fimmu.2024.1388721. eCollection 2024.
8
Arming Vδ2 T Cells with Chimeric Antigen Receptors to Combat Cancer.用嵌合抗原受体武装Vδ2 T细胞以对抗癌症。
Clin Cancer Res. 2024 Aug 1;30(15):3105-3116. doi: 10.1158/1078-0432.CCR-23-3495.
9
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy.新型来源的 CAR 产品:癌症免疫治疗突破的新途径。
Front Immunol. 2024 Apr 11;15:1378739. doi: 10.3389/fimmu.2024.1378739. eCollection 2024.
10
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy.γδT 细胞工程的进展:为增强癌症免疫疗法铺平道路。
Front Immunol. 2024 Mar 21;15:1360237. doi: 10.3389/fimmu.2024.1360237. eCollection 2024.